Michael Weintraub Appointed to Board of Directors
Newfire Global Partners Announces Appointment of Michael Weintraub to its Board of Directors
Newfire Global Partners, a leading service provider that helps technology companies bring innovation to market, today announced that Michael Weintraub has been appointed to its Board of Directors, effective immediately.
“Michael is a business leader and operator who has consistently disrupted the status quo by bringing meaningful innovation to market,” said Stephen S. Hau, chairman and CEO, Newfire Partners. “His experience and success as both entrepreneur and investor will be invaluable to Newfire Partners and to our customers in today’s demanding business environment.”
“I have had the pleasure to watch the Newfire Partners team in action, helping businesses build, modernize, and scale,” said Michael Weintraub. “They are trusted partners to entrepreneurs, operators, and investors. I look forward to working with them.”
Background on Michael Weintraub
Michael is Co-Founder and Managing partner of Ardan Equity Partners, a healthcare enterprise software private equity firm. He was most recently Managing Partner of Optum Ventures, a leading health services company focused on digital health innovation. Michael previously co-founded and served as CEO of Humedica, a pioneer and leader in the field of population health management and big data. In 2013, Humedica was acquired by UnitedHealth Group (UHG), and he broadened his role within the company to become President and CEO of Optum Analytics. Prior to launching Humedica, Michael served as senior managing director at Leerink Partners, a leading healthcare investment bank. He was also president and CEO of PHARMetrics, a healthcare informatics company, which was acquired by IMS Health (now IQVIA) in 2005.
Michael serves as Founding Chairman of the Board of Phreesia, as well as Chairman of the Board of BroadReach, a global healthcare company headquartered in Cape Town, South Africa. He holds Board Director positions at Oncology Analytics and The College Diabetes Network (CDN), is an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital, and is an Entrepreneur in Residence at Harvard Business School.
Michael received his MBA from Harvard Business School and earned his bachelor’s degree in Economics from Brandeis University.